Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the role of the pulmonary vasculature in the
development and progression of chronic obstructive pulmonary disease (COPD). To accomplish
this, an inhaled prostacyclin (iloprost) will be given to patients with COPD and changes in
oxidative stress and lung volumes during exercise will be measured.
Phase:
Phase 2
Details
Lead Sponsor:
Louisiana State University Health Sciences Center in New Orleans